KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Current Taxes: 2023-2025

Historic Current Taxes for Xenon Pharmaceuticals (XENE) over the last 1 years, with Sep 2025 value amounting to $231,000.

  • Xenon Pharmaceuticals' Current Taxes was N/A to $231,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $231,000, marking a year-over-year change of. This contributed to the annual value of $5.7 million for FY2024, which is 1538.62% up from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Current Taxes stood at $231,000 for Q3 2025, which was down 87.38% from $1.8 million recorded in Q2 2025.
  • Xenon Pharmaceuticals' 5-year Current Taxes high stood at $6.6 million for Q1 2025, and its period low was $231,000 during Q3 2025.
  • In the last 3 years, Xenon Pharmaceuticals' Current Taxes had a median value of $1.8 million in 2025 and averaged $2.9 million.
  • Data for Xenon Pharmaceuticals' Current Taxes shows a peak YoY spiked of 1,538.62% (in 2024) over the last 5 years.
  • Over the past 3 years, Xenon Pharmaceuticals' Current Taxes (Quarterly) stood at $347,000 in 2023, then soared by 1,538.62% to $5.7 million in 2024, then reached $231,000 in 2025.
  • Its last three reported values are $231,000 in Q3 2025, $1.8 million for Q2 2025, and $6.6 million during Q1 2025.